How Genes Shape Brain Changes in MS

Credibility

Interest

Key Takeaway

Changes in brain network activity in MS are linked to normal patterns of gene activity, suggesting biology helps explain why some brain areas worsen or adapt over time.

What They Found

Researchers compared brain scans from people with MS and healthy volunteers to map which brain areas showed stronger or weaker connections at rest, a sign of how brain networks are working. Areas in the default-mode network (a group of regions active when the mind is at rest or daydreaming) became more connected in many people with MS; those changes matched genes involved in controlling inflammation and immune response. Other areas, like parts of the salience network (which helps notice important events) and the cerebellum (involved in balance and coordination), had weaker connections and were linked to genes that react to cytokines, small proteins that drive inflammation. People with progressive MS showed more changes in the default-mode network and cerebellum, and those changes matched genes related to how cells package DNA (epigenetics) and how mitochondria make energy. Among patients with thinking or memory problems, stronger connections in the default-mode network and inner temporal lobe matched lower activity of genes that help clear damaged DNA and manage iron, processes that can affect brain cell health.

Who Should Care and Why

People with MS should care because the study links brain changes seen on MRI to built-in gene activity, helping explain why some brain regions get worse or try to compensate over time—like how a neighborhood’s response to a storm depends on its layout and resources. Caregivers can use this idea to understand that symptoms (for example, memory problems or balance trouble) may come from specific brain networks being more vulnerable or trying to adapt. Clinicians and therapists may use this knowledge to focus monitoring or rehabilitation on the networks most likely involved, similar to focusing repair crews where damage and risk are highest. Patients on or considering treatments that affect inflammation or iron metabolism might find these results relevant, because related genes were tied to network changes. Overall, this helps personalize expectations: two people with similar scans may have different risks or recovery patterns because their brain regions differ in the genes that influence damage and repair.

Important Considerations

This study finds links between where brain networks change in MS and where certain genes are normally active, but it does not prove the genes cause those brain changes—correlation is not the same as cause. The gene data came from a separate healthy brain atlas, so individual patients’ gene activity may differ from the atlas patterns used here. Also, while the findings point to biological clues (like inflammation, energy use, and iron handling), they don’t immediately change treatment—more research is needed before this guides specific medical decisions.

AI-generated summary — for informational purposes only, not medical advice

Categories:

Early Research MS Progression MS Genetics

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Translational psychiatry often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News